Policy Influence NPC conducts policy-relevant research on value of patient access to innovative medicines and informs policy discussions, presenting opportunities to position our solutions as essential tools for healthcare payers, policymakers, and regulatory bodies seeking robust evidence for coverage decisions.

Disparities Insight Recent collaboration with University of Washington on racial and ethnic disparities in prescription drug utilization highlights a demand for equity-focused data and analyses, presenting opportunities to offer targeted health equity analytics and payer-focused interventions.

Public Engagement Active presence in media, Congressional testimony, and industry events such as ASCO suggests a receptive audience for sponsored research, policy briefs, and executive-branded thought leadership to influence decision-makers in oncology and beyond.

Growth Leadership Leadership expansions and key hires in research and policy indicate a growing, strategic organization open to consulting, custom research partnerships, and multi-year collaboration with pharma sponsors and healthcare payers.

Financial Scale With a mid-market revenue profile and a focused staff size, NPC represents a cost-effective partner for rigorous policy research, evidence generation, and strategic communications services tailored to value-based reimbursement initiatives.